Tachyarrhythmias During Hospitalization for COVID-19 or Multisystem Inflammatory Syndrome in Children and Adolescents.
COVID‐19
multisystem inflammatory syndrome in children (MIS‐C)
tachyarrhythmia
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
18 10 2022
18 10 2022
Historique:
pubmed:
18
10
2022
medline:
21
10
2022
entrez:
17
10
2022
Statut:
ppublish
Résumé
Background Cardiac complications related to COVID-19 in children and adolescents include ventricular dysfunction, myocarditis, coronary artery aneurysm, and bradyarrhythmias, but tachyarrhythmias are less understood. The goal of this study was to evaluate the frequency, characteristics, and outcomes of children and adolescents experiencing tachyarrhythmias while hospitalized for acute severe COVID-19 or multisystem inflammatory syndrome in children. Methods and Results This study involved a case series of 63 patients with tachyarrhythmias reported in a public health surveillance registry of patients aged <21 years hospitalized from March 15, 2020, to December 31, 2021, at 63 US hospitals. Patients with tachyarrhythmias were compared with patients with severe COVID-19-related complications without tachyarrhythmias. Tachyarrhythmias were reported in 22 of 1257 patients (1.8%) with acute COVID-19 and 41 of 2343 (1.7%) patients with multisystem inflammatory syndrome in children. They included supraventricular tachycardia in 28 (44%), accelerated junctional rhythm in 9 (14%), and ventricular tachycardia in 38 (60%); >1 type was reported in 12 (19%). Registry patients with versus without tachyarrhythmia were older (median age, 15.4 [range, 10.4-17.4] versus 10.0 [range, 5.4-14.8] years) and had higher illness severity on hospital admission. Intervention for treatment of tachyarrhythmia was required in 37 (59%) patients and included antiarrhythmic medication (n=31, 49%), electrical cardioversion (n=11, 17%), cardiopulmonary resuscitation (n=8, 13%), and extracorporeal membrane oxygenation (n=9, 14%). Patients with tachyarrhythmias had longer hospital length of stay than those who did not, and 9 (14%) versus 77 (2%) died. Conclusions Tachyarrhythmias were a rare complication of acute severe COVID-19 and multisystem inflammatory syndrome in children and adolescents and were associated with worse clinical outcomes, highlighting the importance of close monitoring, aggressive treatment, and postdischarge care.
Identifiants
pubmed: 36250670
doi: 10.1161/JAHA.122.025915
pmc: PMC9673680
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e025915Subventions
Organisme : NIDDK NIH HHS
ID : K23 DK119463
Pays : United States
Références
JAMA Pediatr. 2017 Oct 2;171(10):e172352
pubmed: 28783810
Am J Cardiol. 2014 Nov 1;114(9):1400-5
pubmed: 25200339
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
Lancet. 2020 May 23;395(10237):1607-1608
pubmed: 32386565
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
N Engl J Med. 2020 Apr 23;382(17):1663-1665
pubmed: 32187458
Circ Arrhythm Electrophysiol. 2021 Mar;14(3):e009458
pubmed: 33554620
Am J Cardiol. 2014 Feb 1;113(3):535-40
pubmed: 24332245
JAMA. 2020 Jul 21;324(3):259-269
pubmed: 32511692
N Engl J Med. 2020 Jul 23;383(4):334-346
pubmed: 32598831
Circulation. 2021 Aug 10;144(6):e123-e135
pubmed: 34229446
J Clin Med. 2020 Mar 20;9(3):
pubmed: 32244983
Circulation. 2017 Apr 25;135(17):e927-e999
pubmed: 28356445
JACC Clin Electrophysiol. 2020 Sep;6(9):1193-1204
pubmed: 32972561
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
JAMA. 2021 Mar 16;325(11):1074-1087
pubmed: 33625505
N Engl J Med. 2020 Jul 23;383(4):347-358
pubmed: 32598830
Arch Dis Child. 2021 Feb 16;:
pubmed: 33593743
Nat Rev Cardiol. 2020 May;17(5):259-260
pubmed: 32139904